USD 2.96 Billion
Drug Discovery Informatics Market Size, Share, Growth Analysis, By Workflow(Discovery Informatics and Development Informatics), By Mode(Outsourced, and In-house), By Services(Sequence Analysis Platforms, Molecular Modeling, Docking, Clinical Trial Data Management), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2209 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
89
|Figures:
76
Drug Discovery Informatics Market Insights
Drug Discovery Informatics Market size was valued at USD 3.29 Billion in 2023 and is poised to grow from USD 3.66 Billion in 2024 to USD 0 Billion by 2032, growing at a CAGR of 11.30% during the forecast period (2025-2032).
The drug discovery informatics market is expected to rise in the coming years as a result of advances in high-performance computing and online services, increased usage of in-silico modeling techniques, a growing volume of drug development data, and rising demand for innovative pharmaceutical moieties. The introduction of improved drug discovery information technologies is expected to heighten industry competition. Certara, Inc., for example, released version 20 of its Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulation’s platform in January 2021. The new models aid in assessing and analyzing medication activity throughout pregnancy and breastfeeding.
Furthermore, it assists clients in making key decisions regarding optimizing drug safety and efficacy profiles. Companies are also growing implementing informatics technologies to reduce the lengthy drug research schedule. Curve Therapeutics Ltd., for example, will handle its biologically encoded Microcycle platform in 2021 using the CDD Vault platform. It is a widely used hosted platform for applications in pharmaceutical, biotechnology, & academic institutes for the secure and frictionless sharing of data in real-time, encouraging collaborative discoveries.
In addition, more rapid Covid-19 medication discovery around the globe is adding to market growth. For example, in order to provide quick solutions, scientists used virtual screening using drugs from the DrugBank to target viral proteins in and human ACE2 receptors. These investigations relied on silico techniques for screening small compounds with the potential to be used in drug discovery against Covid-19.
Similarly, companies are developing a variety of digital services and solutions to aid in the various stages of drug development for Covid-19. for example, the IBM visual molecular explorer platform investigated a subset of the produced compounds targeting the coronavirus (SARS-CoV-2). The explorer's open-source sharing of AI-generated artifacts aided in the early stages of optimal medication design.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Discovery Informatics
Fastest Growth
Discovery Informatics
Growth Rate
11.30% CAGR
Global Drug Discovery Informatics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Drug Discovery Informatics Market Segmental Analysis
The global drug discovery informatics market is segmented based on workflow, mode, services, application, end-use, and region. In terms of workflow, the market is segmented into discovery informatics, and development informatics. On the basis of categorization by mode, the market is segmented into outsourced, and in-house. Based on services, the market is segmented into sequence analysis platforms, molecular modeling, docking, clinical trial data management, and other services. Based on region the global drug discovery informatics market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drug Discovery Informatics Market Analysis by Workflow
Discovery informatics dominated the market with a 59.19% share in 2022 due to a strong focus on the production of precision pharmaceuticals. Precision medicine is the practice of personalizing medical care for specific patients using genetic & molecular analysis. PerkinElmer, Inc., for example, provides development informatics solutions for using analytics to accelerate drug discovery.
Furthermore, governments in numerous underdeveloped nations are encouraging the use of bioinformatics for quick pharmaceutical development. For example, in 2020, the Indian government established the Drug Discovery Hackathon (DDH). It is a training programme aimed at facilitating the development of an effective molecule for the Covid-19 virus through the use of drug discovery information systems with potential applications in the identification, validation, design, and synthesis of lead molecules.
Due to the growing number of medicine candidates in pharmaceutical companies' pipelines, the drug development process segment is predicted to grow at the quickest CAGR of 11.69% from 2022 to 2028. These tools are used to conduct certain tasks in clinical trial design in order to improve overall trial performance the most.
Drug Discovery Informatics Market Analysis by Mode
The outsourced mode segment led the market, accounting for 51.21% in 2022 of the total revenue. The category will grow at a steady CAGR over the forecast period due to an increase in partnerships among pharmaceutical firms and contractor development and manufacturing organizations (CDMOs). Contract Research Organizations (CROs) are involved in the preparation of reports on novel drug entities, which are then used by the sponsoring organization or drug manufacturer to submit to the US FDA.
There are advantages when pharmaceutical and biotechnology businesses collaborate with a CRO that uses the same informatics system. The common informatics platform used by the CRO and companies aids in tracking the progress of research in the same way as their own internal studies do. This assists the corporation in cost-cutting and productivity gains, which are predicted to provide market entities with enormous profit prospects.
The in-house mode segment is expected to grow at the greatest compound annual growth rate of 11.73% from 2023 to 2030, owing to increased adoption of technological innovations by large-scale companies for drug discovery due to advantages such as providing direct access to information from a wide range of sources, avoiding lengthy data gathering in addition reformatting, and assisting in the combination of cross-disciplinary information.
Global Drug Discovery Informatics Market By Workflow (%)
To get detailed analysis on other segments, Request For Free Sample Report
Drug Discovery Informatics Market Regional Insights
North America held the greatest market share of 39.30% in 2022; growth in the region may be ascribed to a number of factors, including an elevated prevalence of infectious illnesses, rapid adoption of new and advanced R&D technologies, and the presence of major companies. Furthermore, businesses in the region are concentrating on joint ventures and research partnerships that are expected to fuel market expansion in the future years.
Asia-Pacific is anticipated to expand rapidly from 2022 to 2028, owing to the growth of the pharmaceutical nanotechnology industry and constant software development in the region.
Global Drug Discovery Informatics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drug Discovery Informatics Market Dynamics
Drug Discovery Informatics Market Drivers
Increasing Demand for Novel Drugs
- The growing prevalence of various diseases and the need for effective treatment options have led to an increased demand for novel drugs. Drug discovery informatics plays a crucial role in accelerating the drug discovery process by enabling efficient data analysis, predictive modeling, and virtual screening, thus driving market growth.
Drug Discovery Informatics Market Restraints
High Implementation Costs
- Implementing drug discovery informatics systems and technologies can involve substantial upfront costs, including software licenses, hardware infrastructure, and skilled personnel. These high implementation costs can be a barrier for smaller companies or institutions with limited financial resources, restraining market growth.
Request Free Customization of this report to help us to meet your business objectives.
Drug Discovery Informatics Market Competitive Landscape
The competitive landscape of the global drug discovery informatics market is characterized by the presence of several companies offering a range of software solutions, platforms, and services for various stages of the drug discovery process. These companies compete based on factors such as product features, performance, scalability, customer support, and pricing. For example, Charles River Laboratories International, Inc. partnered with Deciphex. The Patholytix Preclinical platform from Deciphex will aid in increasing pathologist productivity by getting data to clients more quickly. This aided in the expansion of the company's market portfolio.
Drug Discovery Informatics Market Top Player’s Company Profiles
- Accelrys (Biovia)
- Schrödinger
- Certara
- Collaborative Drug Discovery (CDD)
- Optibrium
- Chemical Computing Group (CCG)
- IBM Watson Health
- PerkinElmer
- BioSolveIT
- Entelos
- Dassault Systèmes Biovia
- XtalPi Inc.
- OpenText
- Benchling
- MedChemica Ltd.
- ChemAxon
- BioSymetrics Inc.
Drug Discovery Informatics Market Recent Developments
-
Evotec and the Crohn's & Colitis Foundation joined forces in January 2024 to research and develop novel treatments for inflammatory bowel disease (IBD). As part of this collaboration, both businesses will leverage Evotec's extensive research and development (R&D) infrastructure to progress the development of two novel therapeutic targets, fibrosis and compromised intestinal barrier function.
-
Simcyp Biopharmaceutics software, which Certara unveiled in November 2023, is designed to make the process of developing novel and generic medication formulations more efficient. The Simcyp Biopharmaceutics program is intended to help scientists, formulationists, and biopharmaceuticists formulate complicated, innovative, and generic small molecule medications efficiently and economically.
-
A cloud-native SaaS platform called Signals Research Suite was introduced by Revvity, Inc. in December 2023 with the goal of accelerating the discovery of drugs and materials. It facilitates scientific cooperation between researchers in different R&D fields, such as medicine development and specialized chemical material creation. The new solution is a strong solution that covers the full drug development process, from early research and in vitro testing and safety to early development and specialty chemical new product development. It includes the VitroVivo, Inventa, and Revvity Signals Notebook tools.
Drug Discovery Informatics Key Market Trends
- Increasing Adoption of Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are being increasingly integrated into drug discovery informatics to enhance efficiency and accuracy. These technologies enable advanced data analysis, predictive modeling, and virtual screening, leading to accelerated drug discovery processes and improved success rates.
- Rising Demand for Cloud-based Informatics Solutions: Cloud computing has gained significant popularity in the drug discovery informatics market. Cloud-based informatics solutions offer scalability, flexibility, and cost-effectiveness, allowing organizations to efficiently store, manage, and analyze large volumes of data. They also facilitate remote collaboration and data sharing among research teams, leading to increased adoption.
- Focus on Personalized Medicine and Targeted Therapies: The shift towards personalized medicine and targeted therapies has influenced the drug discovery informatics market. Informatics solutions play a vital role in identifying specific biomarkers, analyzing patient data, and designing tailored treatments. The growing emphasis on precision medicine is driving the development of informatics tools that enable personalized drug discovery approaches.
- Integration of Big Data Analytics: The availability of large-scale genomic, proteomic, and clinical data has led to the integration of big data analytics in drug discovery informatics. Advanced analytics techniques such as data mining, pattern recognition, and predictive modeling enable researchers to derive valuable insights, identify novel drug targets, and optimize drug discovery processes.
Drug Discovery Informatics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global drug discovery informatics market analysis, the drug discovery informatics market is expected to rise in the coming years as a result of advances in high-performance computing and online services, increased usage of in-silico modeling techniques, a growing volume of drug development data, and rising demand for innovative pharmaceutical moieties. The introduction of improved drug discovery information technologies is expected to heighten industry competition. : The shift towards personalized medicine and targeted therapies has influenced the drug discovery informatics market. Informatics solutions play a vital role in identifying specific biomarkers, analyzing patient data, and designing tailored treatments. The growing emphasis on precision medicine is driving the development of informatics tools that enable personalized drug discovery approaches.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 3.29 Billion |
| Market size value in 2032 | USD 0 Billion |
| Growth Rate | 11.30% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Drug Discovery Informatics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Drug Discovery Informatics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Drug Discovery Informatics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Drug Discovery Informatics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Drug Discovery Informatics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Drug Discovery Informatics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
